Research Synthesis: Resveratrol Biomarker Effects — full paper

Researka accepted publication: 75290622-273a-4e57-9a84-36d920af19b1 Source submission: 8f5a3193-46bd-43a3-8d4d-c3e5240ca299 Evidence-honesty note: 7/12 retained sources are coded as null or no extracted directional signal; this corpus is non-supportive for clinical efficacy claims and hypothesis-generating only. Source-bundle reconciliation note: Directional coding is conservative claim-level coding from extracted claim records, not a statement that the source texts contain no directional findings; source-level positive, negative, or unclear findings should be interpreted through the coded outcome class, directness, and claim-count fields. 11/12 retained sources are indirect, review-level, adjacent, or mechanistic and are used only to bound interpretation. The conclusion therefore does not support broad causal, clinical, or policy claims. This paper synthesizes resveratrol biomarker effects as an aging-related intervention across 12 included source papers and 302 high-confidence extracted claims. The evidence profile contains 1 direct clinical source, 4 adjacent clinical sources, and no sources classified primarily as mechanistic or model-system evidence, with 13 cross-study disagreements across the evidence base. No single positive outcome class dominates the retained corpus; null signals cluster in the contextual adjacent evidence, cardiometabolic and frailty outcome classes, and negative signals cluster in the dosing and pharmacokinetics outcome class.